E3 ligase ligand-linker conjugate inhibitor, (S,R,S)-AHPC-PEG2-NH2, Purity ≥98%

Cat. No.: X24-09-YM715

E3 ligase ligand-linker conjugate inhibitor, (S,R,S)-AHPC-PEG2-NH2, Purity ≥98%

Synonym: 2010159-60-9; VH032-PEG2-NH2; VHL ligand-linker conjugate 3; E3 ligase ligand-linker conjugate 6 free base; (2S,4R)-1-[(2S)-2-[[2-[2-(2-Aminoethoxy)ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide; E3 ligase ligand-linker conjugate inhibitor

  • CAS Number: 2010159-60-9
  • Compound CID: 131704497
Product Size
100 mg; 200 mg; 500 mg; 1 g
Price
Datasheet
MSDS
Properties
Description
(S,R,S)-AHPC-PEG2-NH2 is an effective PROTAC inhibitor, that has the ability to prevent the pathway of E3 ligase ligand-linker conjugation. The molecular weight of the compound is 575.72, and its molecular formula is C28H41N5O6S.
Molecular Weight
575.72
Molecular Formula
C28H41N5O6S
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
(S,R,S)-AHPC-PEG2-NH2 can be studied extensively for its potential therapeutic applications in the treatment of oncology.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0